Tratamiento de cáncer de pulmón metastásico (estadio IV) de célula no pequeña : consenso de expertos, Asociación Colombiana de Hematología y Oncología (ACHO).

Introduction: Lung cancer (LC) is the most frequent cause of death from oncological diseases in the world1 , reporting worldwide incidence rates for both sexes of 23.1 cases per 100,000 inhabitants and a mortality rate of 19.4% according to Globocan 20122 . Objective: To agree upon recommendations for the management of non-small cell metastatic lung cancer (stage IV), in the Colombian context. Methods: A consensus of experts comprised by 17 clinical oncologists, active members of the Colombian Association of Hematology and Oncology (ACHO), who work in the main institutions of the country. It was carried out in four phases: in the first phase 22 questions were structured, which were rated from 1 to 9, in the second phase the non-consensual questions were re-sent, in the third phase the answers and the answers were analyzed and discussed. The non-consensual ones went to a fourth phase where a nominal consensus was made. Results: 25 questions related to the treatment of non-small cell metastatic lung cancer (stage IV) were evaluated and conclusions were reached based on the best scientific evidence and internationally recognized oncology management guides adapted to the Colombian context and reality. Conclusions: Treatments for advanced lung cancer should be considered according to the best scientific evidence and availability in Colombia, in order to offer the best treatment to the patient. This consensus is a tool to guide clinical decision making and is useful as a support document for consultations with public and private entities. It is important to mention that this is an academic-scientific and non-regulatory document.